1. | 变性淋巴瘤激酶(anapastic lymphoma kinase) 辉瑞的间变性淋巴瘤激酶(ALK)抑制剂Crizotinib是一种靶向治疗的晚期药物,研究结果引起研究者和医生不小的轰动。Crizotinib … www.labbase.net|基于942个网页 |
2. | 淋巴瘤激酶(anaplastic lymphoma kinase) 间变型淋巴瘤激酶(ALK)在肿瘤细胞生长和发展过程中起关键作用,ALK基因可通过与EML4基因形成融合基因来编码产生AL… www.mdweekly.com.cn|基于454个网页 |
3. | Automated Lamellar Keratoplasty ...atomileusis (LASIK), and automated lamellar keratoplasty(ALK) alter corneal shape and power to achieve the refractive goal. www.eyenet.com.cn|基于59个网页 |
4. | |
5. | |
6. |